Elucidation of the physicochemical properties and potency of siRNA-loaded small-sized lipid nanoparticles for siRNA delivery

详细信息    查看全文

• 作者：Yusuke Sato^a ; ¹ ; Yusuke Note^a ; ¹ ; Masatoshi Maeki^b ; Noritada Kaji^c ; ^d ; Yoshinobu Baba^c ; ^d ; Manabu Tokeshi^b ; ^d ; Hideyoshi Harashima^a ; ^{harasima@pharm.hokudai.ac.jp" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Small-sized lipid nanoparticles ; siRNA delivery ; Microfluidic device ; Protein adsorption ; Stability ; Endosomal escape
• 刊名：Journal of Controlled Release
• 出版年：2016
• 出版时间：10 May 2016
• 年：2016
• 卷：229
• 期：Complete
• 页码：48-57
• 全文大小：1788 K

文摘

Because nanoparticles with diameters less than 50 nm penetrate stromal-rich tumor tissues more efficiently, the synthesis of small-sized nanoparticles encapsulating short interfering RNA (siRNA) is important in terms of realizing novel siRNA medicine for the treatment of various cancers. Lipid nanoparticles (LNPs) are the leading systems for the delivery of siRNA in vivo. Limit size LNPs were successfully synthesized using a microfluidic mixing technique. However, the physicochemical properties and potential for in vivo siRNA delivery of the limit-size LNPs have not been examined in detail. In the present study, we prepared LNPs with different diameters from 32 to 67 nm using a microfluidic mixing devise and examined the physicochemical properties of the particles and the potential for their use in delivering siRNA in vitro and in vivo to liver. Reducing the size of the LNPs causes poor-packing and an increased surface area, which result in their instability in serum. Moreover, it was revealed that the ability of endosomal escape (cytosolic siRNA release) of the smaller LNPs is subject to inhibition by serum compared to that of larger counterparts. Taken together, an increase in packing and avoiding the adsorption of serum components are key strategies for the development of next-generation highly potent and small-sized LNPs.